nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—DRD5—eyelid—leprosy	0.112	0.169	CbGeAlD
Cabergoline—HTR1B—trigeminal nerve—leprosy	0.0506	0.0761	CbGeAlD
Cabergoline—HTR1D—trigeminal nerve—leprosy	0.049	0.0737	CbGeAlD
Cabergoline—HTR1B—cranial nerve—leprosy	0.0361	0.0543	CbGeAlD
Cabergoline—HTR1D—cranial nerve—leprosy	0.0349	0.0525	CbGeAlD
Cabergoline—HTR7—cranial nerve—leprosy	0.0278	0.0418	CbGeAlD
Cabergoline—HTR2A—trigeminal nerve—leprosy	0.0243	0.0366	CbGeAlD
Cabergoline—DRD1—nerve—leprosy	0.0228	0.0343	CbGeAlD
Cabergoline—HTR7—peripheral nervous system—leprosy	0.0183	0.0275	CbGeAlD
Cabergoline—HTR2A—cranial nerve—leprosy	0.0173	0.0261	CbGeAlD
Cabergoline—Pericarditis—Thalidomide—leprosy	0.0167	0.0498	CcSEcCtD
Cabergoline—HTR2A—hindlimb—leprosy	0.0146	0.022	CbGeAlD
Cabergoline—HTR1B—blood vessel—leprosy	0.0145	0.0218	CbGeAlD
Cabergoline—HTR7—nerve—leprosy	0.0143	0.0214	CbGeAlD
Cabergoline—HTR1D—blood vessel—leprosy	0.0141	0.0211	CbGeAlD
Cabergoline—DRD2—nerve—leprosy	0.0135	0.0203	CbGeAlD
Cabergoline—ADRA2A—peripheral nervous system—leprosy	0.0134	0.0202	CbGeAlD
Cabergoline—HTR2A—appendage—leprosy	0.0125	0.0189	CbGeAlD
Cabergoline—Toothache—Thalidomide—leprosy	0.0119	0.0354	CcSEcCtD
Cabergoline—HTR2A—peripheral nervous system—leprosy	0.0114	0.0172	CbGeAlD
Cabergoline—HTR7—blood vessel—leprosy	0.0112	0.0168	CbGeAlD
Cabergoline—DRD4—testis—leprosy	0.0104	0.0156	CbGeAlD
Cabergoline—Psychotic disorder—Dapsone—leprosy	0.01	0.0298	CcSEcCtD
Cabergoline—Pleural effusion—Thalidomide—leprosy	0.00943	0.0281	CcSEcCtD
Cabergoline—HTR2A—nerve—leprosy	0.00889	0.0134	CbGeAlD
Cabergoline—Influenza—Dapsone—leprosy	0.00885	0.0264	CcSEcCtD
Cabergoline—Acne—Thalidomide—leprosy	0.00858	0.0256	CcSEcCtD
Cabergoline—Arthropathy—Thalidomide—leprosy	0.00794	0.0237	CcSEcCtD
Cabergoline—Dyskinesia—Thalidomide—leprosy	0.00768	0.0229	CcSEcCtD
Cabergoline—HTR1D—eye—leprosy	0.00748	0.0112	CbGeAlD
Cabergoline—DRD3—nervous system—leprosy	0.00716	0.0108	CbGeAlD
Cabergoline—HTR2A—blood vessel—leprosy	0.00698	0.0105	CbGeAlD
Cabergoline—DRD5—nervous system—leprosy	0.00671	0.0101	CbGeAlD
Cabergoline—Cramps of lower extremities—Thalidomide—leprosy	0.00663	0.0198	CcSEcCtD
Cabergoline—Lightheadedness—Thalidomide—leprosy	0.00646	0.0193	CcSEcCtD
Cabergoline—Mental disability—Thalidomide—leprosy	0.00627	0.0187	CcSEcCtD
Cabergoline—Euphoric mood—Thalidomide—leprosy	0.0062	0.0185	CcSEcCtD
Cabergoline—HTR2B—skin of body—leprosy	0.00605	0.0091	CbGeAlD
Cabergoline—DRD2—eye—leprosy	0.00563	0.00847	CbGeAlD
Cabergoline—Vertigo—Dapsone—leprosy	0.00554	0.0165	CcSEcCtD
Cabergoline—ADRA1B—nervous system—leprosy	0.0055	0.00828	CbGeAlD
Cabergoline—ADRA1D—nervous system—leprosy	0.00538	0.0081	CbGeAlD
Cabergoline—Cardiac failure—Thalidomide—leprosy	0.00537	0.016	CcSEcCtD
Cabergoline—Osteoarthritis—Thalidomide—leprosy	0.00524	0.0156	CcSEcCtD
Cabergoline—Disturbance in sexual arousal—Thalidomide—leprosy	0.0052	0.0155	CcSEcCtD
Cabergoline—DRD1—nervous system—leprosy	0.00513	0.00772	CbGeAlD
Cabergoline—Psychotic disorder—Thalidomide—leprosy	0.00512	0.0153	CcSEcCtD
Cabergoline—Face oedema—Thalidomide—leprosy	0.00506	0.0151	CcSEcCtD
Cabergoline—Blood creatinine increased—Thalidomide—leprosy	0.00491	0.0146	CcSEcCtD
Cabergoline—Liver function test abnormal—Thalidomide—leprosy	0.00484	0.0144	CcSEcCtD
Cabergoline—Orthostatic hypotension—Thalidomide—leprosy	0.00479	0.0143	CcSEcCtD
Cabergoline—HTR2B—tendon—leprosy	0.00461	0.00693	CbGeAlD
Cabergoline—Insomnia—Dapsone—leprosy	0.00455	0.0136	CcSEcCtD
Cabergoline—Influenza—Thalidomide—leprosy	0.00453	0.0135	CcSEcCtD
Cabergoline—Bronchitis—Thalidomide—leprosy	0.00436	0.013	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Thalidomide—leprosy	0.00421	0.0126	CcSEcCtD
Cabergoline—HTR1B—nervous system—leprosy	0.00416	0.00625	CbGeAlD
Cabergoline—Weight increased—Thalidomide—leprosy	0.00412	0.0123	CcSEcCtD
Cabergoline—Gastrointestinal pain—Dapsone—leprosy	0.00412	0.0123	CcSEcCtD
Cabergoline—Weight decreased—Thalidomide—leprosy	0.0041	0.0122	CcSEcCtD
Cabergoline—Pneumonia—Thalidomide—leprosy	0.00406	0.0121	CcSEcCtD
Cabergoline—Depression—Thalidomide—leprosy	0.00403	0.012	CcSEcCtD
Cabergoline—HTR1D—nervous system—leprosy	0.00402	0.00605	CbGeAlD
Cabergoline—HTR2C—nervous system—leprosy	0.00399	0.006	CbGeAlD
Cabergoline—Abdominal pain—Dapsone—leprosy	0.00398	0.0119	CcSEcCtD
Cabergoline—HTR7—tendon—leprosy	0.00395	0.00593	CbGeAlD
Cabergoline—ADRB1—nervous system—leprosy	0.00391	0.00588	CbGeAlD
Cabergoline—Epistaxis—Thalidomide—leprosy	0.00381	0.0114	CcSEcCtD
Cabergoline—HTR2B—nervous system—leprosy	0.00374	0.00563	CbGeAlD
Cabergoline—HTR2A—eye—leprosy	0.00371	0.00559	CbGeAlD
Cabergoline—Rhinitis—Thalidomide—leprosy	0.00364	0.0108	CcSEcCtD
Cabergoline—ADRA2C—tendon—leprosy	0.00363	0.00545	CbGeAlD
Cabergoline—Oedema peripheral—Thalidomide—leprosy	0.00357	0.0107	CcSEcCtD
Cabergoline—Visual impairment—Thalidomide—leprosy	0.00349	0.0104	CcSEcCtD
Cabergoline—Cardiac disorder—Thalidomide—leprosy	0.00337	0.01	CcSEcCtD
Cabergoline—HTR1A—nervous system—leprosy	0.00335	0.00505	CbGeAlD
Cabergoline—HTR7—testis—leprosy	0.00327	0.00491	CbGeAlD
Cabergoline—Arrhythmia—Thalidomide—leprosy	0.00324	0.00966	CcSEcCtD
Cabergoline—HTR7—nervous system—leprosy	0.00321	0.00482	CbGeAlD
Cabergoline—Alopecia—Thalidomide—leprosy	0.0032	0.00956	CcSEcCtD
Cabergoline—Vomiting—Dapsone—leprosy	0.0032	0.00954	CcSEcCtD
Cabergoline—Headache—Dapsone—leprosy	0.00315	0.0094	CcSEcCtD
Cabergoline—Flatulence—Thalidomide—leprosy	0.00311	0.00928	CcSEcCtD
Cabergoline—Tension—Thalidomide—leprosy	0.0031	0.00924	CcSEcCtD
Cabergoline—ADRA1A—nervous system—leprosy	0.00309	0.00465	CbGeAlD
Cabergoline—DRD2—testis—leprosy	0.00309	0.00465	CbGeAlD
Cabergoline—Nervousness—Thalidomide—leprosy	0.00307	0.00915	CcSEcCtD
Cabergoline—Back pain—Thalidomide—leprosy	0.00305	0.00911	CcSEcCtD
Cabergoline—Muscle spasms—Thalidomide—leprosy	0.00303	0.00905	CcSEcCtD
Cabergoline—DRD2—nervous system—leprosy	0.00303	0.00456	CbGeAlD
Cabergoline—ADRA2C—testis—leprosy	0.003	0.00452	CbGeAlD
Cabergoline—Nausea—Dapsone—leprosy	0.00299	0.00892	CcSEcCtD
Cabergoline—ADRA2C—nervous system—leprosy	0.00295	0.00443	CbGeAlD
Cabergoline—Ill-defined disorder—Thalidomide—leprosy	0.00293	0.00874	CcSEcCtD
Cabergoline—ADRA2A—tendon—leprosy	0.00289	0.00435	CbGeAlD
Cabergoline—Malaise—Thalidomide—leprosy	0.00285	0.00849	CcSEcCtD
Cabergoline—Vertigo—Thalidomide—leprosy	0.00284	0.00846	CcSEcCtD
Cabergoline—Syncope—Thalidomide—leprosy	0.00283	0.00844	CcSEcCtD
Cabergoline—Palpitations—Thalidomide—leprosy	0.00279	0.00832	CcSEcCtD
Cabergoline—Loss of consciousness—Thalidomide—leprosy	0.00277	0.00828	CcSEcCtD
Cabergoline—Hypertension—Thalidomide—leprosy	0.00273	0.00813	CcSEcCtD
Cabergoline—Arthralgia—Thalidomide—leprosy	0.00269	0.00802	CcSEcCtD
Cabergoline—Anxiety—Thalidomide—leprosy	0.00268	0.00799	CcSEcCtD
Cabergoline—Discomfort—Thalidomide—leprosy	0.00266	0.00792	CcSEcCtD
Cabergoline—Dry mouth—Thalidomide—leprosy	0.00263	0.00784	CcSEcCtD
Cabergoline—Confusional state—Thalidomide—leprosy	0.0026	0.00775	CcSEcCtD
Cabergoline—Oedema—Thalidomide—leprosy	0.00258	0.00768	CcSEcCtD
Cabergoline—Shock—Thalidomide—leprosy	0.00253	0.00756	CcSEcCtD
Cabergoline—Hyperhidrosis—Thalidomide—leprosy	0.00249	0.00743	CcSEcCtD
Cabergoline—HTR2A—tendon—leprosy	0.00246	0.0037	CbGeAlD
Cabergoline—Anorexia—Thalidomide—leprosy	0.00246	0.00733	CcSEcCtD
Cabergoline—Hypotension—Thalidomide—leprosy	0.00241	0.00718	CcSEcCtD
Cabergoline—ADRA2A—testis—leprosy	0.0024	0.0036	CbGeAlD
Cabergoline—ADRA2A—nervous system—leprosy	0.00235	0.00354	CbGeAlD
Cabergoline—Musculoskeletal discomfort—Thalidomide—leprosy	0.00235	0.007	CcSEcCtD
Cabergoline—Insomnia—Thalidomide—leprosy	0.00233	0.00695	CcSEcCtD
Cabergoline—Paraesthesia—Thalidomide—leprosy	0.00231	0.0069	CcSEcCtD
Cabergoline—Dyspnoea—Thalidomide—leprosy	0.0023	0.00685	CcSEcCtD
Cabergoline—Somnolence—Thalidomide—leprosy	0.00229	0.00683	CcSEcCtD
Cabergoline—Dyspepsia—Thalidomide—leprosy	0.00227	0.00676	CcSEcCtD
Cabergoline—Decreased appetite—Thalidomide—leprosy	0.00224	0.00668	CcSEcCtD
Cabergoline—Fatigue—Thalidomide—leprosy	0.00222	0.00663	CcSEcCtD
Cabergoline—Pain—Thalidomide—leprosy	0.0022	0.00657	CcSEcCtD
Cabergoline—Constipation—Thalidomide—leprosy	0.0022	0.00657	CcSEcCtD
Cabergoline—Feeling abnormal—Thalidomide—leprosy	0.00212	0.00633	CcSEcCtD
Cabergoline—Gastrointestinal pain—Thalidomide—leprosy	0.00211	0.00628	CcSEcCtD
Cabergoline—HTR2A—testis—leprosy	0.00204	0.00306	CbGeAlD
Cabergoline—Abdominal pain—Thalidomide—leprosy	0.00204	0.00608	CcSEcCtD
Cabergoline—HTR2A—nervous system—leprosy	0.002	0.00301	CbGeAlD
Cabergoline—Hypersensitivity—Thalidomide—leprosy	0.0019	0.00566	CcSEcCtD
Cabergoline—CYP3A4—nervous system—leprosy	0.00185	0.00278	CbGeAlD
Cabergoline—Asthenia—Thalidomide—leprosy	0.00185	0.00551	CcSEcCtD
Cabergoline—Pruritus—Thalidomide—leprosy	0.00182	0.00544	CcSEcCtD
Cabergoline—Diarrhoea—Thalidomide—leprosy	0.00176	0.00526	CcSEcCtD
Cabergoline—Dizziness—Thalidomide—leprosy	0.0017	0.00508	CcSEcCtD
Cabergoline—Vomiting—Thalidomide—leprosy	0.00164	0.00489	CcSEcCtD
Cabergoline—Rash—Thalidomide—leprosy	0.00162	0.00485	CcSEcCtD
Cabergoline—Dermatitis—Thalidomide—leprosy	0.00162	0.00484	CcSEcCtD
Cabergoline—Headache—Thalidomide—leprosy	0.00161	0.00481	CcSEcCtD
Cabergoline—Nausea—Thalidomide—leprosy	0.00153	0.00456	CcSEcCtD
